查看文章

The debate over the propriety of cognitive enhancement evokes both enthusiasm and worry. To gain further insight into the reasons that people may have for endorsing or eschewing pharmacological enhancement (PE), we used empirical tools to explore public attitudes towards PE of twelve cognitive, affective, and social (CAS) domains (e.g., attention, mood, creativity). Participants (N = 1,408) from Canada and the United States were recruited using Mechanical Turk and were randomly assigned to read one (and only one) vignette that described an individual who uses a pill to enhance a single domain. After reading the vignette, participants were asked how comfortable they were with the individual using the enhancement. People were significantly more comfortable when they read about enhancement of certain CAS domains (e.g. creativity) than others (e.g. mood). We found a modest negative …